Price and preferred manufacturer of generic capmatinib drugs
Capmatinib (Capmatinib), as an important drug for the treatment of metastatic non-small cell lung cancer, has been launched in many countries around the world and is widely used in clinical practice. With the expiration of the patent, a number of generic drugs of capmatinib have also been released, providing patients with more treatment options. Generic drugs are drugs that are similar in pharmaceutical equivalence and bioequivalence to the original drug and are produced by other pharmaceutical companies after the patent protection period of the original drug has expired.

Capmatinib, with its potent and selective methionine receptor inhibition, has demonstrated significant in vitro and in vivo anti-tumor effects in multiple methionine-driven cancer models. Especially in the treatment of advanced non-small cell lung cancer patients with MET exon 14 skipping mutations, capmatinib has shown excellent efficacy, especially for those patients who have not yet received treatment.
Currently, there are multiple versions of capmatinib generics available on the market, produced by well-known brands such as Laos Lucius Pharmaceuticals, Daxiong Pharmaceuticals, United Pharmaceuticals, and Element Pharmaceuticals. The common specifications of these generic drugs are 200mg 56 tablets and 200mg 60 tablets. The price of each box is roughly between 3,000 and 4,000 yuan, but the specific price may change due to factors such as exchange rate fluctuations.
When choosing a generic capmatinib drug, patients should consider factors such as the quality of the drug, the reputation of the manufacturer, and the price of the drug. Several pharmaceutical manufacturers mentioned above enjoy a good reputation in the market, and their product quality is guaranteed, so they are the first choice of patients. At the same time, patients should also pay attention to the packaging, labeling and other information of the medicine when purchasing to ensure that the medicine purchased is a qualified product produced through regular channels.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)